Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 89 | NANETS2022 | Next issue

NANETS 2022

ea0089p1 | Population Science | NANETS2022

Cervical Neuroendocrine Carcinomas: A Population-Based Analysis of Clinicopathologic Characteristics and Survival Outcomes in Comparison with Conventional Cervical Malignancies

Diamantopoulos Leonidas N. , Korentzelos Dimitrios , Makrakis Dimitrios , Bhargava Rohit

Background: Cervical neuroendocrine carcinomas (CNECs) are a rare and heterogeneous group of cervical neoplasms, with very limited data regarding epidemiology and survival. In this study, we explored clinicopathologic factors and oncologic outcomes of patients with CNECs derived from the Survival, Epidemiology and End Results (SEER) database, in comparison to cervical squamous cell carcinoma (SCC) and adenocarcinoma (AC).Methods: The SEER database (18 re...

ea0089p2 | Population Science | NANETS2022

Factors Impacting Survival Outcomes of Islet Cell Carcinoma

Chu Tiffany , Hu Robert W. , Silberstein Peter T.

Background: Islet cell carcinomas are low-grade tumors originating from the islets of Langerhans. Despite the indolent nature of these tumors, metastasis is often detected upon initial diagnosis, at which point the mean survival is approximately 2 years. In this study, we aim to investigate disparities that exist in these patients and how facility variables, patient demographics, and palliative care (PC) utilization contribute to differences in survival outcomes.<p class="...

ea0089p3 | Population Science | NANETS2022

Socioeconomic Factors, Treatment Modality, and Survival in Islet Cell Carcinoma: A National Cancer Database Analysis

Hu Robert W. , Chu Tiffany , Silberstein Peter T.

Background: Islet cell carcinoma is a rare cancer of neuroendocrine origin. There has yet to be a study analyzing the treatment type and survival outcomes in this cancer. In this study, we utilized a national database to understand the correlations between patient demographics, socioeconomic factors, modality of treatment, and survival.Methods: The National Cancer Database was queried to identify patients diagnosed with islet cell carcinoma (ICD-O-3 hist...

ea0089p4 | Population Science | NANETS2022

Carcinoid Heart Disease in Patients Diagnosed with Small Bowel and Lung Neuroendocrine Tumors

MD, MSc Julie Hallet , MD, MPH Katrina Duncan , MD, MPH Simron Singh , MSc Victoria Barabash , MD Shaheeda Ahmed , MD Sten Myrehaug , MD, MPH Natalie Coburn , MD, MPH Calvin Law

Background: Carcinoid heart disease (CHD) is a complication of neuroendocrine tumors (NETs). While its pathophysiology and manifestations are described, little is known about its occurrence in all patients diagnosed with NETs. We examined the occurrence of CHD and explored the use of echocardiography after diagnosis of NET.Methods: We conducted a population-based retrospective cohort study of adults diagnosed with small bowel and lung NETs (2000-2019). C...

ea0089p5 | Population Science | NANETS2022

Comparison of Demographics and Overall Survival (OS) Among Patients with Young-Onset(YO) and Late-Onset(LO) GI Neuroendocrine Tumors/Carcinomas (NETs/NECs) in the United States

Laderian Bahar , Farha Nicole , Khorana Alok , Krishnamurthi Smitha , (Auston) Wei Wei , Estfan Bassam , Gorgun Emre , Berber Eren , Gill Amanjit , Fojo Tito

Background: More than 12,000 people are diagnosed with neuroendocrine malignancies each year in the US. There are limited data on YO-NETs/YO-NECs. In the present study, we seek to evaluate clinical characteristics/trends of patients with GI-YO-NETs and GI-YO-NECs.Methods: Using the National Cancer DataBase, NCDB, we identified 124,081 GI-NETs and 52,063 GI-NEC cases 18 or older, diagnosed between 2004 and 2019. Histology codes to identify NETs and NECs w...

ea0089p6 | Population Science | NANETS2022

Evaluating the Impact of Education on Clinician Integration of Guidelines, Real-World Data, and Patient Perspectives on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Ackbarali, PhD Tariqa , Lovelace Cindy

Background: Targeted therapies for somatostatin receptor-positive NETs have seen significant developments in recent years. Approved and investigational somatostatin analogs for GEP-NETs are changing the treatment landscape for these cancers allowing for better management of difficult-to-treat heterogeneous tumors. To improve competence in applying these advances and to consider patient perspectives in treatment selection, an educational initiative was designed in collaboration...

ea0089p7 | Population Science | NANETS2022

Feasibility of e-NET: A Web-Based Health Platform to Investigate Quality of Life in Patients with Neuroendocrine Tumors

Mulvey Claire K. , Steiding Paige , Moon Farhana , Paciorek Alan , Zhang Li , Bergsland Emily K.

Background: Patients with neuroendocrine neoplasms (NENs) have chronic symptoms from hormone overproduction, tumor growth and metastasis, and side effects from prolonged treatment. We assessed the feasibility of using a digital health platform to recruit patients with NENs to evaluate symptoms and quality of life.Methods: eNET is a prospective, web-based, cohort study for patients with advanced NENs of any primary site, histologic grade, differentiation,...

ea0089p8 | Population Science | NANETS2022

Multivisceral Surgical Resection of Locally Advanced Pancreatic Neuroendocrine Tumor is Associated with a Survival Benefit

Hernandez, MD Matthew C. , Sullivan, MD Kevin M. , Melstrom, MD Laleh G. , Fong, MD Yuman , MD Gagandeep Singh

Background: In patients with locally advanced pancreatic neuroendocrine tumors (PNET), surgical resection is associated with improved survival. There is a paucity of data whether there is a benefit for multivisceral resection for locally advanced PNET compared to pancreatectomy alone. This study investigated the association of surgical resection on overall survival comparing pancreas specific and multivisceral resection for PNET.Methods: The Surveillance...

ea0089p9 | Population Science | NANETS2022

Lifestyle and Neuro-endocrine Tumor (NET) Development Within the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort

Bogaards, BSc Marit , May, PhD Anne.M. , Onland-Moret, PhD N. Charlotte , J. Cross, PhD Amanda , Eriksson, PhD Linda , D. Valk, MD, PhD Gerlof , Girard, MD Nicolas , Gunter, PhD Marc , Walter, MD PhD Thomas , Lantuejoul, MD, PhD Sylvie , S. van Leeuwaarde, MD, PhD Rachel S.

Background: There has been increasing interest in the relationship between lifestyle and NET. Results from previously published small observational studies indicate that smoking, alcohol and diabetes may contribute to NET development, but the reported data is conflicting. Additionally, little data is available on diet and physical activity. The aim of the current study is to investigate the association between lifestyle factors and NET development in a large prospective cohort...

ea0089p10 | Population Science | NANETS2022

Environmental Pollution and GEP-NENS – Is There an Association?

Ituarte, PhD Philip H. G. , MA Nora Ruel , MD Daneng Li , MD Gagandeep Singh

Background: Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NEMs) is increasing, but etiology of sporadic, non-familial disease remains obscure. Behavioral risk factors like smoking and alcohol consumption may be associated with GEP-NENs, yet environmental factors potentially associated with GEP-NENs remain unexamined. We regressed age-adjusted incidence rates for GEP-NENs cases in California (CA) on county-level pollution data to determine if an association ...